person · Reporting owner

BARASCH RICHARD A

Disclosed activity across 4 companies

Tapewire entity: 76540
SEC CIK: 0001076341

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AdaptHealth Corp.AHCO · Entity 5183	Director	June 18, 2024	June 24, 2024
CareMax, Inc.CMAX · Entity 87127	Director	June 08, 2021	June 10, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AdaptHealth Corp.

Report date June 18, 2024 · Filed June 24, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	438,355	Reported balance After 2024-06-18 transaction · row 1 1 source row Row 1 · 2024-06-18 · Tax withholding · Disposed 3,559 · Balance 438,355 F1: The reporting person surrendered 3,559 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant.

Filing footnotes · ownership attribution and instrument terms

F1: The reporting person surrendered 3,559 shares to satisfy tax withholding liabilities in connection with the vesting of a previously issued restricted stock grant.

CareMax, Inc.

Report date June 08, 2021 · Filed June 10, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	50,000	Reported balance After 2021-06-08 transaction · row 1 1 source row Row 1 · 2021-06-08 · Conversion · Acquired 50,000 · Balance 50,000 F1: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis.
Class B Common StockSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2021-06-08 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2021-06-08 · Conversion · Disposed 50,000 · Balance 0 F1: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis.

Filing footnotes · ownership attribution and instrument terms

F1: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Starling Oncology, Inc.

Report date August 12, 2025 · Filed August 14, 2025

Section 16 reporting ended · disclosed 2025-08-14. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

UNIVERSAL AMERICAN CORP.

Report date April 28, 2017 · Filed May 02, 2017

Section 16 reporting ended · disclosed 2017-05-02. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-04-28 transaction · row 1 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 1 · 2017-04-28 · Disposition to issuer · Disposed 1,664,791 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-04-28 transaction · row 2 Sequence does not reconcile; account continuity is unresolved. 1 source row Row 2 · 2017-04-28 · Disposition to issuer · Disposed 423,468 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Merger Consideration, subject to conditions set forth in the Merger Agreement.
Common StockSEC Table I · non-derivative	IndirectBy Wife	Reported balance After 2017-04-28 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2017-04-28 · Disposition to issuer · Disposed 222,077 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectBy Son (Benjamin)	Reported balance After 2017-04-28 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2017-04-28 · Disposition to issuer · Disposed 28,180 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectBy Daughter (Natalie)	Reported balance After 2017-04-28 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 5 · 2017-04-28 · Disposition to issuer · Disposed 23,080 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectBy Daughter (Emily)	Reported balance After 2017-04-28 transaction · row 6 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 6 · 2017-04-28 · Disposition to issuer · Disposed 30,124 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectTara Acquisition LLC	Reported balance After 2017-04-28 transaction · row 7 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 7 · 2017-04-28 · Disposition to issuer · Disposed 215,835 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectHB Family Trust #1	Reported balance After 2017-04-28 transaction · row 8 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 8 · 2017-04-28 · Disposition to issuer · Disposed 33,872 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectBarasch Family Trust #3	Reported balance After 2017-04-28 transaction · row 9 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 9 · 2017-04-28 · Disposition to issuer · Disposed 494,400 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Common StockSEC Table I · non-derivative	IndirectBarasch Family Trust #1	Reported balance After 2017-04-28 transaction · row 10 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 10 · 2017-04-28 · Disposition to issuer · Disposed 220,768 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.18	Direct	Reported balance After 2017-04-28 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2017-04-28 · Disposition to issuer · Disposed 300,000 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.05	Direct	Reported balance After 2017-04-28 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2017-04-28 · Disposition to issuer · Disposed 234,597 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.05	Direct	Reported balance After 2017-04-28 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2017-04-28 · Disposition to issuer · Disposed 78,200 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.41	Direct	Reported balance After 2017-04-28 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2017-04-28 · Disposition to issuer · Disposed 30,784 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.41	Direct	Reported balance After 2017-04-28 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2017-04-28 · Disposition to issuer · Disposed 30,784 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.09	Direct	Reported balance After 2017-04-28 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2017-04-28 · Disposition to issuer · Disposed 21,565 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.09	Direct	Reported balance After 2017-04-28 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2017-04-28 · Disposition to issuer · Disposed 64,696 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.41	Direct	Reported balance After 2017-04-28 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2017-04-28 · Disposition to issuer · Disposed 61,568 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.09	Direct	Reported balance After 2017-04-28 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2017-04-28 · Disposition to issuer · Disposed 21,565 · Balance 0 F3: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.09	Direct	Reported balance After 2017-04-28 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2017-04-28 · Disposition to issuer · Disposed 64,696 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration").

F2: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Merger Consideration, subject to conditions set forth in the Merger Agreement.

F3: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time.

F4: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 16, 2021 Filed Nov 18, 2021 20:43 UTC	Starling Oncology, Inc. TOI · Entity 5327	PurchaseCommon Stock	1,000	$10.12	$10,115.00	Disclosure SEC source: 0001104659-21-141467 · tm2133425-5_4seq1.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,113 Read SEC document
November 12, 2021 Filed Nov 16, 2021 21:59 UTC	Starling Oncology, Inc. TOI · Entity 5327	ConversionClass B Common Stock · Derivative	100,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-140230 · tm2132979-16_4seq1.xml · derivative · entry 3 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. F1 · price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. F1 · derivative.exercise_date: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. F1 · derivative.expiration_date: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. Read SEC document
November 12, 2021 Filed Nov 16, 2021 21:59 UTC	Starling Oncology, Inc. TOI · Entity 5327	Disposition to issuerCommon Stock	14,887	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-140230 · tm2132979-16_4seq1.xml · nonDerivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,113 F1 · price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. F2 · acquired: On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surivivng corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7. Read SEC document
November 12, 2021 Filed Nov 16, 2021 21:59 UTC	Starling Oncology, Inc. TOI · Entity 5327	ConversionCommon Stock	100,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-140230 · tm2132979-16_4seq1.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. F2 · price: On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surivivng corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7. F1 · acquired: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as deifned below), and have no expiration date. F2 · acquired: On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acqusitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surivivng corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7. Read SEC document
November 12, 2021 Filed Nov 18, 2021 20:22 UTC Amendment	Starling Oncology, Inc. TOI · Entity 5327	Exercise / conversionClass B Common Stock · Derivative	100,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-141455 · tm2133425-1_4aseq1.xml · derivative · entry 3 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 100,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date. F1 · price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date. F1 · derivative.exercise_date: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date. F1 · derivative.expiration_date: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date. Read SEC document
November 12, 2021 Filed Nov 18, 2021 20:22 UTC Amendment	Starling Oncology, Inc. TOI · Entity 5327	Disposition to issuerCommon Stock	14,887	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-141455 · tm2133425-1_4aseq1.xml · nonDerivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,113 F3 · price: On November 12, 2021, in connection with the Business Combination, Mr. Barasch, forfeited 14,887 of his shares of the Issuer's common stock to the Issuer pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, by and among, DFP And TOI and certain DFP directors and officers, including Mr. Barasch. F3 · acquired: On November 12, 2021, in connection with the Business Combination, Mr. Barasch, forfeited 14,887 of his shares of the Issuer's common stock to the Issuer pursuant to the Stockholder Support Agreement, dated as of June 28, 2021, by and among, DFP And TOI and certain DFP directors and officers, including Mr. Barasch. Read SEC document
November 12, 2021 Filed Nov 18, 2021 20:22 UTC Amendment	Starling Oncology, Inc. TOI · Entity 5327	Exercise / conversionCommon Stock	100,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-141455 · tm2133425-1_4aseq1.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date. F2 · price: On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7. F1 · acquired: The shares of Class B common stock converted into shares of the Issuer's Class A common stock on a one for basis in connection with the Business Combination (as defined below), and have no expiration date. F2 · acquired: On November 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as June 28, 2021, by and among DFP Healthcare Acquisitions Corp. ("DFP"), Orion Merger Sub I, Inc. ("First Merger Sub"), Orion Merger Sub II, LLC ("Second Merger Sub"), and TOI Parent, Inc. ("Old TOI"), First Merger Sub merged into Old TOI, with Old TOI being the surviving corporation then Old TOI merged into Second Merger Sub, with Second Merger Sub being the surviving entity and a wholly owned subsidiary of DFP, which then changed its name to The Oncology Institute, Inc. (such transactions, collectively, the "Business Combination"). In connection with the Business Combination, the Class A common stock was converted to Common Stock of the Issuer, pursuant to a reclassification exempt under Rule 16b-7. Read SEC document
August 23, 2021 Filed Aug 25, 2021 16:30 UTC	AdaptHealth Corp. AHCO · Entity 5183	GrantCommon Stock	9,017	$0.00	$0.00	Disclosure SEC source: 0001104659-21-109351 · tm2124383-11_4.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,937 Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:41 UTC	CareMax, Inc. CMAX · Entity 87127	ConversionClass B Common Stock · Derivative	50,000	$0.00	$0.00	Disclosure SEC source: 0001104659-21-079698 · tm2119285-1_4seq1.xml · derivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 50,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis. F1 · derivative.exercise_date: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis. F1 · derivative.expiration_date: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis. Read SEC document
June 08, 2021 Filed Jun 10, 2021 21:41 UTC	CareMax, Inc. CMAX · Entity 87127	ConversionClass A Common Stock	50,000	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-21-079698 · tm2119285-1_4seq1.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On June 8, 2021, Deerfield Healthcare Technology Acquisitions Corp. consummated its business combination (the "Business Combination") with CareMax Medical Group, LLC and IMC Medical Group Holdings, LLC, with the combined company being renamed "CareMax, Inc." In connection with the consummation of the Business Combination, the shares of Class B common stock automatically converted into shares of Class A common stock on a one-for-one basis. Read SEC document
December 21, 2020 Filed Feb 11, 2021 19:43 UTC	AdaptHealth Corp. AHCO · Entity 5183	GiftClass A Common Stock	15,000	$0.00	$0.00	Disclosure SEC source: 0001104659-21-020935 · tm214849-17_5seq1.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,920 Read SEC document
September 09, 2020 Filed Sep 11, 2020 21:02 UTC	AdaptHealth Corp. AHCO · Entity 5183	GrantClass A Common Stock	9,017	$0.00	$0.00	Disclosure SEC source: 0001104659-20-104528 · a4.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,920 F1 · balance_after: Includes 5,000 shares previously granted to the reporting person that were inadvertently omitted from the reporting person's Form 4 filed on December 18, 2019. Read SEC document
December 16, 2019 Filed Dec 18, 2019 21:31 UTC	AdaptHealth Corp. AHCO · Entity 5183	GrantClass A Common Stock	5,000	$0.00	$0.00	Disclosure SEC source: 0001104659-19-073987 · a4.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document
November 08, 2019 Filed Nov 13, 2019 21:39 UTC	AdaptHealth Corp. AHCO · Entity 5183	OtherPrivate Placement Warrant · Derivative	1,690,000	$0.00 Strike: $11.50	$0.00	Disclosure SEC source: 0001104659-19-063570 · a4.xml · derivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,643,333 Underlying: Common Stock · 1,690,000 shares Expires 2024-11-08 F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F2 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document
November 08, 2019 Filed Nov 13, 2019 21:39 UTC	AdaptHealth Corp. AHCO · Entity 5183	OtherCommon Stock	2,373,152	$0.00	$0.00	Disclosure SEC source: 0001104659-19-063570 · a4.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,672,500 F1 · kind: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F1 · price: Pursuant to the Amended and Restated Assignment Letter Agreement dated October 15, 2019, by and among Deerfield/RAB Ventures, LLC (the "Sponsor"), DFB Healthcare Acquisitions Corp. ("DFB") and AdaptHealth Holdings, LLC ("AdaptHealth"), the Sponsor transferred and assigned 2,373,152 of its founder shares of DFB and 1,690,000 warrants to purchase shares of DFB's Class A Common Stock held by the Sponsor to certain members and employees of AdaptHealth, for no consideration. F2 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document
April 02, 2018 Filed Apr 3, 2018 16:57 UTC	AdaptHealth Corp. DFBH · Entity 5183	OtherCommon Stock	921,848	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-18-022201 · a4.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,045,652 F1 · kind: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376). F1 · price: 921,848 shares were forfeited to the Issuer at no cost in connection with the expiration of the underwriters' over-allotment option, as described in the Issuer's registration statement on Form S-1, as amended (File No. 333-222376). F2 · ownership.nature: The shares are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document
February 21, 2018 Filed Feb 23, 2018 17:31 UTC	AdaptHealth Corp. DFBH · Entity 5183	PurchasePrivate Placement Warrant · Derivative	4,333,333	$1.50 Strike: $11.50	$6,499,999.50	Disclosure SEC source: 0001104659-18-011752 · a4.xml · derivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,333,333 Underlying: Common Stock · 4,333,333 shares Expires not disclosed F1 · derivative.exercise_date: The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination or February 21, 2019. F2 · derivative.expiration_date: The warrants expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation. F3 · ownership.nature: The securities are held directly by Deerfield/RAB Ventures, LLC and indirectly by Deerfield Private Design Fund IV, L.P., as member of Deerfield/RAB Ventures, LLC, Richard Barasch, as member and manager of Deerfield/RAB Ventures, LLC, and Steven Hochberg, as manager of Deerfield/RAB Ventures, LLC. Each of Deerfield Private Design Fund IV, L.P. and Messrs. Barasch and Hochberg disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	64,696	Not disclosed Strike: $6.09	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 20 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,696 shares Expires not disclosed F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	21,565	Not disclosed Strike: $6.09	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 19 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,565 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	61,568	Not disclosed Strike: $8.41	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 18 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 61,568 shares Expires not disclosed F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	64,696	Not disclosed Strike: $6.09	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 17 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,696 shares Expires not disclosed F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	21,565	Not disclosed Strike: $6.09	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 16 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,565 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	30,784	Not disclosed Strike: $8.41	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 15 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,784 shares Expires not disclosed F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	30,784	Not disclosed Strike: $8.41	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 14 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,784 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	78,200	Not disclosed Strike: $6.05	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 13 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,200 shares Expires not disclosed F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. F4 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time, subject to conditions set forth in the Merger Agreement. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	234,597	Not disclosed Strike: $6.05	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 12 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234,597 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerStock Options (Right to Buy) · Derivative	300,000	Not disclosed Strike: $6.18	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · derivative · entry 11 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each of these stock options was cancelled and converted into the right to receive a cash payment equal to the excess, if any, of the Per Share Merger Consideration over the per share exercise price of such stock option multiplied by the aggregate number of shares of common stock in respect of such stock option immediately before the Effective Time. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	220,768	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 10 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Barasch Family Trust #1 Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	494,400	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 9 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Barasch Family Trust #3 Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	33,872	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 8 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · HB Family Trust #1 Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	215,835	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 7 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Tara Acquisition LLC Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	30,124	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 6 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter (Emily) Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	23,080	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 5 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter (Natalie) Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	28,180	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 4 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Son (Benjamin) Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	222,077	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 3 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	423,468	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each of these unvested shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Merger Consideration, subject to conditions set forth in the Merger Agreement. Read SEC document
April 28, 2017 Filed May 2, 2017 19:01 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Disposition to issuerCommon Stock	1,664,791	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-000935 · es1700587_4-barasch.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of November 17, 2016 (the "Merger Agreement"), by and among Universal American Corp. (the "Company"), WellCare Health Plans, Inc. and Wind Merger Sub, Inc., at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock was cancelled and converted into the right to receive an amount in cash equal to the per share merger consideration of $10.00 (the "Per Share Merger Consideration"). Read SEC document
March 04, 2017 Filed Mar 7, 2017 17:20 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Tax withholdingCommon Stock	11,164	$9.96	$111,193.44	Disclosure SEC source: 0001593968-17-000410 · primary_01.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,088,259 F1 · shares: Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock. F2 · balance_after: Represents common stock including 423,468 shares of unvested restricted stock. Read SEC document
February 13, 2017 Filed Feb 14, 2017 17:55 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Tax withholdingCommon Stock	10,055	$9.96	$100,147.80	Disclosure SEC source: 0001593968-17-000289 · primary_01.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,099,423 F1 · shares: Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock. F2 · balance_after: Represents common stock including 443,468 shares of unvested restricted stock. Read SEC document
February 06, 2017 Filed Feb 7, 2017 16:40 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Exercise / conversionStock Option (Right to Buy) · Derivative	400,000	$7.87 Strike: $7.87	$3,148,000.00	Disclosure SEC source: 0001593968-17-000221 · primary_01.xml · derivative · entry 6 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 400,000 shares Expires 2017-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Options are fully vested. Read SEC document
February 06, 2017 Filed Feb 7, 2017 16:40 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Tax withholdingCommon Stock	20,317	$9.96	$202,357.32	Disclosure SEC source: 0001593968-17-000221 · primary_01.xml · nonDerivative · entry 5 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,109,478 F1 · shares: Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock. F5 · balance_after: Represents common stock including 461,481 shares of unvested restricted stock. Read SEC document
February 06, 2017 Filed Feb 7, 2017 16:40 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Tax withholdingCommon Stock	362,872	$9.96	$3,614,205.12	Disclosure SEC source: 0001593968-17-000221 · primary_01.xml · nonDerivative · entry 4 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,129,795 F6 · shares: Shares surrendered to issuer in payment of exercise price and tax liability in connection with stock option exercise. F5 · balance_after: Represents common stock including 461,481 shares of unvested restricted stock. Read SEC document
February 06, 2017 Filed Feb 7, 2017 16:40 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Exercise / conversionCommon Stock	400,000	$7.87	$3,148,000.00	Disclosure SEC source: 0001593968-17-000221 · primary_01.xml · nonDerivative · entry 3 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,492,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · balance_after: Represents common stock including 461,481 shares of unvested restricted stock. Read SEC document
February 04, 2017 Filed Feb 7, 2017 16:40 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Tax withholdingCommon Stock	12,855	$9.98	$128,292.90	Disclosure SEC source: 0001593968-17-000221 · primary_01.xml · nonDerivative · entry 2 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,092,667 F3 · shares: Shares withheld by issuer to satisfy statutory tax withholding on vesting of performance shares. F4 · balance_after: Represents common stock including 497,878 shares of unvested restricted stock. Read SEC document
February 04, 2017 Filed Feb 7, 2017 16:40 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	Tax withholdingCommon Stock	12,855	$9.98	$128,292.90	Disclosure SEC source: 0001593968-17-000221 · primary_01.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,105,522 F1 · shares: Shares withheld by issuer to satisfy statutory tax withholding on vesting of restricted stock. F2 · balance_after: Represents common stock including 520,907 shares of unvested restricted stock. Read SEC document
February 02, 2017 Filed Feb 3, 2017 17:08 UTC	UNIVERSAL AMERICAN CORP. UAM · Entity 176574	GrantCommon Stock	140,813	$0.00	$0.00	Disclosure SEC source: 0001593968-17-000197 · primary_01.xml · nonDerivative · entry 1 BARASCH RICHARD A · CIK 0001076341 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,118,377 F1 · shares: Represents grant of restricted stock which vests in four equal annual installments beginning February 2, 2018. F2 · balance_after: Represents common stock including 543,936 shares of unvested restricted stock. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.